Anticoagulants, Antiplatelets, and Thrombolytics
During the past decade, remarkable progress has been made in the development of newer drugs to prevent and treat thromboembolic disorders, such as oral direct anti-Xa and anti-IIa antagonists, as well as oral antiplatelet ADP antagonists with rapid onset and offset. In addition, there has been concentrated effort aimed at identifying novel uses of traditional antithrombotic drugs, such as aspirin, heparin, and oral anticoagulants, as well as combinations of agents, such as more than one antiplatelet, antiplatelet with anticoagulant, antiplatelet with or without thrombolytic. Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition pr…
Mehr
CHF 197.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V113:
Lieferbar in ca. 20-45 Arbeitstagen
Produktdetails
- ISBN: 978-1-4939-6097-2
- EAN: 9781493960972
- Produktnummer: 23923315
- Verlag: Springer Nature EN
- Sprache: Englisch
- Erscheinungsjahr: 2016
- Seitenangabe: 316 S.
- Masse: H25.4 cm x B17.8 cm 625 g
- Auflage: 2. A.
- Abbildungen: Tabellen, schwarz-weiss
- Reihenbandnummer: 663
- Gewicht: 625
6 weitere Werke von Shaker A. (Hrsg.) Mousa:
Bewertungen
Anmelden